Interacted genes from RAID,miRTarBase |
ZBTB10,FGG,TFAP2C,C15orf52,PPM1D,BACE1,PLAG1,HUWE1,VEGFA,NUMB,IRGQ,MYCN,SUV420H2,MORF4L1,NKIRAS2
more »
ZBTB10,FGG,TFAP2C,C15orf52,PPM1D,BACE1,PLAG1,HUWE1,VEGFA,NUMB,IRGQ,MYCN,SUV420H2,MORF4L1,NKIRAS2,DDX21,COL7A1,FBN1,USP22,MMP15,CDV3,COL4A1,SH3GLB1,CDC42,DNMT3B,TIMM44,U2SURP,FAM105B,PSMA2,PDHX,BCL11A,CHIC2,KDM5B,FAM102B,IGFBP1,TMTC3,HMGCR,TDG,RNF19A,FAM126B,AKT3,R3HDM4,GNB4,ZNF45,KIAA0895,SPIN4,COL4A2,CTC1,PTER,ADO,FAM123B,DNMT3A,PPP1R13B,MMS19,CCNT2,C14orf43,BCKDHA,FREM2,DICER1,BCL2L2,MKL2,BCL2,WNT4,KCTD15,BACH2,XK,TXNDC16,COL1A2,KIAA1549,GAPDH,COL21A1,RAB30,MMP24,FGA,OIP5,PPT1,CDC42SE1,SPARC,SRSF10,MTHFD2,COL1A1,PURG,NOB1,SOWAHC,C12orf76,CDK6,MCL1,PPP1R14C,JUN,IRF2BP2,ANKRD13C,TIPRL,KLHL28,FGB,DCAF12,BFAR,STK19,LAMC1,CEP68,PRKAB2,COL15A1,WSB2,COL3A1,SCAF11,CDC23
|
|
KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
hsa04510
|
Focal adhesion |
JUN,COL3A1,BCL2,AKT3,COL4A1,VEGFA,COL4A2,LAMC1,COL1A1,COL1A2,CDC42, |
7.70E-7 |
hsa05222
|
Small cell lung cancer |
CDK6,BCL2,AKT3,COL4A1,COL4A2,LAMC1, |
2.75E-4 |
hsa04512
|
ECM-receptor interaction |
COL3A1,COL4A1,COL4A2,LAMC1,COL1A1,COL1A2, |
2.75E-4 |
hsa05200
|
Pathways in cancer |
JUN,CDK6,BCL2,AKT3,COL4A1,VEGFA,COL4A2,LAMC1,WNT4,CDC42, |
3.44E-4 |
hsa05211
|
Renal cell carcinoma |
JUN,AKT3,VEGFA,CDC42, |
1.28E-1 |
|
hsa05212
|
Pancreatic cancer |
CDK6,AKT3,VEGFA,CDC42, |
1.39E-1 |
hsa04722
|
Neurotrophin signaling pathway |
JUN,BCL2,AKT3,CDC42, |
5.63E-1 |
hsa04610
|
Complement and coagulation cascades |
FGB,FGG,FGA, |
8.51E-1 |
hsa04370
|
VEGF signaling pathway |
AKT3,VEGFA,CDC42, |
9.80E-1 |
|
|
|
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0001568
|
blood vessel development |
JUN,COL15A1,COL3A1,VEGFA,MKL2,DICER1,COL1A1,COL1A2, |
6.52E-4 |
GO:0001944
|
vasculature development |
JUN,COL15A1,COL3A1,VEGFA,MKL2,DICER1,COL1A1,COL1A2, |
7.52E-4 |
GO:0030168
|
platelet activation |
COL3A1,FGB,FGG,FGA, |
9.05E-4 |
GO:0016569
|
covalent chromatin modification |
HUWE1,MORF4L1,USP22,SUV420H2,DNMT3A,DNMT3B, |
9.42E-4 |
GO:0030198
|
extracellular matrix organization |
COL3A1,COL4A2,LAMC1,COL1A1,COL1A2, |
3.48E-2 |
|
GO:0051726
|
regulation of cell cycle |
JUN,CDK6,BCL2,CDC23,USP22,CCNT2,PPP1R13B,CDC42, |
3.63E-2 |
GO:0008406
|
gonad development |
BCL2,BCL2L2,VEGFA,WNT4,HMGCR, |
4.54E-2 |
GO:0034330
|
cell junction organization |
BCL2,LAMC1,NUMB,CDC42, |
4.79E-2 |
GO:0016568
|
chromatin modification |
HUWE1,MORF4L1,USP22,SUV420H2,KDM5B,DNMT3A,DNMT3B, |
5.96E-2 |
GO:0048608
|
reproductive structure development |
BCL2,BCL2L2,VEGFA,WNT4,HMGCR, |
6.87E-2 |
GO:0048754
|
branching morphogenesis of a tube |
BCL2,MYCN,VEGFA,DICER1, |
6.91E-2 |
GO:0035239
|
tube morphogenesis |
BCL2,MYCN,VEGFA,DICER1,WNT4, |
7.06E-2 |
GO:0045137
|
development of primary sexual characteristics |
BCL2,BCL2L2,VEGFA,WNT4,HMGCR, |
7.06E-2 |
GO:0010035
|
response to inorganic substance |
JUN,BCL2,FGB,COL1A1,FGG,FGA, |
7.68E-2 |
GO:0006916
|
anti-apoptosis |
BCL2,BCL2L2,VEGFA,SH3GLB1,BFAR,MCL1, |
7.84E-2 |
GO:0048730
|
epidermis morphogenesis |
BCL2,COL1A1,COL1A2, |
9.71E-2 |
GO:0001763
|
morphogenesis of a branching structure |
BCL2,MYCN,VEGFA,DICER1, |
9.88E-2 |
|
|
|
|
|
|
KEGG pathways and Gene Ontology terms enriched for the interacted genes of ncRNA from RAID and miRTarBase.
|